B. Guerette et al., CONTROL OF INFLAMMATORY DAMAGE BY ANTI-LFA-1 - INCREASE SUCCESS OF MYOBLAST TRANSPLANTATION, Cell transplantation, 6(2), 1997, pp. 101-107
Myoblast transplantation is a potential treatment for Duchenne Muscula
r Dystrophy. This article confirms by experiments in mice that one pro
blem that has limited the success of clinical trials of this procedure
is a rapid (within 3 days) inflammatory reaction which kills most of
the injected myoblasts, The death of the transplanted myoblasts can be
prevented by treating the host with a mAb against LFA-1. This led to
a 27-fold increase in the number of muscle fibers expressing a reporte
r gene present in the donor myoblasts when the host is also adequately
immunosuppressed with FK506, Therefore, both the nonspecific inflamma
tory reaction and the specific immune response should be adequately co
ntrolled following myoblast transplantation. (C) 1997 Elsevier Science
Inc.